发明名称 |
Utilización del 14,15-dihidro-20,21-dinoreburnamenin14-ol para tratar y/o prevenir las depresiones mayores |
摘要 |
14,15-Dihydro-20,21-dinor-14-eburnameninol (I) is used to prepare a pharmaceutical composition for treating or preventing major depression or sleeping-waking cycle disorders. - 14,15-Dihydro-20,21-dinor-14-eburnameninol of formula (I), where the hydrogens at positions 3 and 16 are trans and the hydroxy group is in alpha or beta conformation, is used to prepare a pharmaceutical composition for treating or preventing major depression or sleeping-waking cycle disorders. - An INDEPENDENT CLAIM is also included for the use of (I) to prepare a pharmaceutical composition for treating patients with depression resistant to conventional antidepressants in order to make such patients sensitive to conventional antidepressant treatment. - ACTIVITY - Antidepressant. - MECHANISM OF ACTION - None given. |
申请公布号 |
ES2430252(T3) |
申请公布日期 |
2013.11.19 |
申请号 |
ES20050717501T |
申请日期 |
2005.01.27 |
申请人 |
BIOCORTECH;MARCO POLO PHARMACEUTICALS |
发明人 |
PUJOL, JEAN-FRANCOIS;WEISSMANN, DINAH |
分类号 |
A61K31/4375;A61K9/16;A61K9/20;A61K9/48;A61K31/437;A61K31/4545;A61P25/24 |
主分类号 |
A61K31/4375 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|